|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Elevation Oncology (NASDAQ: ELEV) through any online brokerage.
The latest price target for Elevation Oncology (NASDAQ: ELEV) was reported by HC Wainwright & Co. on December 23, 2021. The analyst firm set a price target for 12.00 expecting ELEV to rise to within 12 months (a possible 111.64% upside). 4 analyst firms have reported ratings in the last year.
The stock price for Elevation Oncology (NASDAQ: ELEV) is $5.67 last updated Fri Jan 21 2022 21:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Elevation Oncology.
Elevation Oncology’s $Q4 earnings are confirmed for after-market on February 20, 2022.
There is no upcoming split for Elevation Oncology.
Elevation Oncology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.